Journal
SCIENCE
Volume 359, Issue 6372, Pages 232-+Publisher
AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aao1503
Keywords
-
Categories
Funding
- U.S. National Institutes of Health [DK113136, DK098310, AI123819, P01 DK046763, U01 DK062413]
- Infect-ERA FUNCOMPATH [PCIN-2014-052]
- Ministerio de Economia y Competitividad [BIO2015-6477-P]
- Swiss National Science Foundation [P2ZHP3_164850]
- Kenneth Rainin Foundation
- Jill Roberts Institute for Research in IBD
- Swiss National Science Foundation (SNF) [P2ZHP3_164850] Funding Source: Swiss National Science Foundation (SNF)
Ask authors/readers for more resources
Intestinal fungi are an important component of the microbiota, and recent studies have unveiled their potential in modulating host immune homeostasis and inflammatory disease. Nonetheless, the mechanisms governing immunity to gut fungal communities (mycobiota) remain unknown. We identified CX3CR1(+) mononuclear phagocytes (MNPs) as being essential for the initiation of innate and adaptive immune responses to intestinal fungi. CX3CR1(+) MNPs express antifungal receptors and activate antifungal responses in a Syk-dependent manner. Genetic ablation of CX3CR1(+) MNPs in mice led to changes in gut fungal communities and to severe colitis that was rescued by antifungal treatment. In Crohn's disease patients, a missense mutation in the gene encoding CX3CR1 was identified and found to be associated with impaired antifungal responses. These results unravel a role of CX3CR1(+) MNPs in mediating interactions between intestinal mycobiota and host immunity at steady state and during inflammatory disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available